A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

NCT02651753 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Lipitor + Lipidil supra
DRUG: CKD-337

Sponsor

Chong Kun Dang Pharmaceutical